Prenetics (PRE) Q3 2026 Earnings Call Transcript
Second-half profit targets were revised to prioritize customer acquisition.
Prenetics (PRE) released its Q3 2026 earnings results, revealing a 40% increase in revenue for IM8's wellness brand. The company expects a significant loss in adjusted EBITDA for the second half of the year, but attributes this to strategic investments in marketing and product development. IM8 revenue grew for six consecutive quarters, reaching $64.1 million, with the strongest month being September at $23.7 million. The company aims to expand its retail presence and enter the Chinese market by the end of 2027.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.